Overview


According to FutureWise analysis the market for Acne Medication in 2023 is US$ 10.47 billion, and is expected to reach US$ 16.33 billion by 2031 at a CAGR of 5.70%.

Acne is a skin-related disorder caused by inflammation of skin glands and hair follicles. It causes blackheads, whiteheads, or pimples. It is most common in teenagers and young adults. Acne vulgaris substantially impacts a patient's quality of life, affecting self-esteem and psychosocial development. Different variants of acne exist, including acne conglobate, acne fulminans, excoriated acne, acne mechanica, chloracne, drug-induced acne, and occupational acne. These interpretations have a similar clinical and histologic appearance to acne vulgaris but differ by clinical setting, severity, and associated symptoms. Furthermore, selecting the most effective acne treatment, whether over-the-counter or prescribed, can be challenging for patients and physicians due to the abundance of available options.

Topical retinoid are the critical element in treating acne, which promotes the exfoliation of dead skin cells and boosts the formation of new skin cells. The new cells then assist in pushing out dead cells and excess oil from the blocked pores. Retinoid also have anti-inflammatory properties. Topical retinoid are used to treat blackheads and whiteheads or comedonal acne. They are also called retinoic acid or vitamin A acid. Retinoids are also used to treat other skin conditions, such as keratosis pilaris and psoriasis. The different topical retinoids available are retinol, adapalene, tretinoin, tazarotene, alitretinoin, and bexarotene. These come in cream, gel, and liquid forms. Retinoid are generally prescribed only after alternative acne treatments have failed.

FutureWise Market Research has published a report that provides an insightful analysis acne medication market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, acne medication market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  •  Almirall SA.
  •  Bausch Health Companies Inc.
  •  GlaxoSmithKline Plc
  •  Johnson and Johnson
  •  Galderma S.A
  •  Mayne Pharma Group Limited
  •  Mylan N.V
  •  Pfizer Inc.
  •  Sun Pharmaceutical Industries Limited
  •  Teva Pharmaceutical Industries Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Acne Medication Market:

  • In September 2022, La Roche-Posay introduced Effaclar Salicylic Acid Acne Treatment Serum specifically for the treatment of adult acne.
  • In October 2022, the new skincare brand AcneSquad launched a new product range for the treatment of acne. These topical products include toners, tonics, and serums, among others.

The growing incidences of acne among teenagers and young adults are the major driver fueling the growth of the acne medication market. This age group, experiencing significant hormonal changes, is susceptible to acne breakouts. Also, modern lifestyle factors such as stress, dietary patterns, and environmental exposures contribute immensely to acne-related issues. This sustained demand for effective treatments highlights the crucial need for advanced and accessible acne medications, boosting continuous innovation and development in the market. Moreover, the increasing demand for personalized skincare solutions has emerged as a significant driver for the acne medication market. Developing customizable therapies tailored to address specific skin needs and concerns holds immense potential. By varying acne types, sensitivities, and treatment choices, these medications align perfectly with the modern consumer's preference for targeted and individualized interventions. This trend improves the effectiveness of acne medications and promotes better relationships between consumers and their products, therefore propelling market growth. However, the adverse effects of acne treatments vary depending on the procedure's selection and the medications. The most common side effects of topical acne medicines are skin irritation and dryness. The possible complications of oral drugs might be more severe. Antibiotics may upset the stomach or cause patients to be light-headed and dizzy. Additionally, oral isotretinoin may cause extreme side effects, mainly if the person is pregnant. Severe congenital disabilities have been noted in infants whose moms took isotretinoin during pregnancy. The drug may also boost the chance of suicidal thoughts and depression and impact liver functioning and cholesterol levels. The safety concerns about acne therapy products are expected to hinder market development.

By Product Type

  •  Prescription Medicine
  •  Over-the-counter (OTC) Medicine

By Formulation

  •  Topical Medication
  •  Oral Medication

By Therapy Type

  •  Retinoid
    •  Topical Retinoid and Combination Retinoid
    •  Oral Retinoid (Isotrentinoin)
  •  Antibiotic
    •  Topical Antibiotic and Combination Antibiotics
    •  Oral Antibiotics
  •  Salicylic Acid
  •  Benzoyl Peroxide

By Acne Type

  •  Inflammatory Acne
  •  Non-inflammatory Acne

By Distribution Channel

  •  Retail Store
  •  Pharmacy and Drug Store
  •  E-Commerce

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to factors like the increase in the prevalence of acne-related diseases, numerous developments related to acne therapeutics, increasing approval of antibiotics for treating acne and its efficacy in managing, increasing consumer concerns about beauty and skincare, easy availability of OTS topical products, growing clinical approvals of drugs, and the launch of novel drugs in the US is anticipated to drive the market growth over the forecast period. For instance, according to the NCBI (National Center for Biotechnology Information), the prevalence of acne affected 9.4% of the global population in 2022. It is the 8th most prevalent condition in the world. Therefore, the above-mentioned factors are likely to propel the target market in the region.

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants
  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Acne Medication Market By Product Type, By Formulation, By Therapy Type, By Acne Type, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches
  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customisation offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Acne Medication Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Product Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Acne Medication Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Product Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Product Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acne Medication Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prescription Medicine
        2. Over-the-counter (OTC) Medicine

  • 8.   Acne Medication Market, By Formulation Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Topical Medication
        2. Oral Medication

  • 9.   Acne Medication Market, By Therapy Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Retinoid
         1.1. Topical Retinoid and Combination Retinoid
         1.2. Oral Retinoid (Isotretinoin)
        2. Antibiotic
         2.1. Topical Antibiotic and Combination Antibiotics
         2.2. Oral Antibiotics
        3. Salicylic Acid
        4. Benzoyl Peroxide

  • 10.   Acne Medication Market, By Acne Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Inflammatory Acne
        2. Non-inflammatory Acne

  • 11.   Acne Medication Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Retail Store
        2. Pharmacy and Drug Store
        3. E-Commerce

  • 12.   North America Acne Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Acne Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Acne Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Acne Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Acne Medication Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Almirall SA.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bausch Health Companies Inc. .
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GlaxoSmithKline Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Johnson and Johnson
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Galderma S.A
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Mayne Pharma Group Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Mylan N.V,
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Pfizer Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Sun Pharmaceutical Industries Limited
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Teva Pharmaceutical Industries Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients